Elevated H 2 O 2 is implicated in many cardiovascular diseases. We previously demonstrated that H 2 O 2 -induced endothelial nitric oxide synthase (eNOS) activation and excessive NO production contribute to vascular cell injury and increases in microvessel permeability. However, the mechanisms of excessive NO-mediated vascular injury and hyperpermeability remain unknown. This study aims to examine the functional role of NO- ] i and microvessel Lp, a pattern similar to that observed in H 2 O 2 -perfused vessels. Importantly, ONOO À caused further activation of eNOS with amplified NO production. We conclude that the augmentation of NOderived ONOO À is essential for H 2 O 2 -induced endothelial Ca 2+ overload and progressively increased microvessel permeability, which is achieved by self-promoted amplifications of NO-dependent signaling cascades. This novel mechanism provides new insight into the reactive oxygen and/or reactive nitrogen species-mediated vascular dysfunction in cardiovascular diseases.
Introduction
Increased production of reactive oxygen species (ROS) has been demonstrated to cause impaired vascular barrier function, resulting in tissue damage and organ dysfunction (Del Maestro et al., 1981; Cai and Harrison, 2000; Zhu and He, 2006; Zhou et al., 2009; Di et al., 2016; Mundi et al., 2017) . Our previous studies demonstrated that hydrogen peroxide (H 2 O 2 ) at a pathophysiologcally relevant concentration (10 lmol/L) induced delayed and progressive increases in endothelial calcium concentration (EC [Ca 2+ ] i ) and microvessel permeability that was attributed to H 2 O 2 -induced excessive nitric oxide (NO) production through endothelial nitric oxide synthase (eNOS) activation (Zhou et al., 2013) .
While physiological levels of NO have been recognized to be essential for the maintenance of many vascular functions, excessive NO has been demonstrated to play important roles in mediating inflammation-induced vascular leakage (Yuan et al., 1993; He et al., 1997; Zhu and He, 2005; Hatakeyama et al., 2006; Zhou and He, 2010; Mundi et al., 2017) . Our previous studies demonstrated that, instead of causing immediate and transient increases in microvessel permeability as observed in inflammatory mediator-stimulated vessels (He et al., 1996; Baluk et al., 1997; Zhu and He, 2005; Jiang et al., 2008; , large amounts of H 2 O 2 -induced NO production resulted in caspase activation and impairment of Ca 2+ homeostasis, leading to vascular cell apoptosis, and delayed and progressive increases in microvessel permeability (Zhou et al., 2013) .
Exogenously supplied NO has been reported to have potential cytotoxic effects in cultured endothelial cells (Shen et al., 1998; Shimizu et al., 1998) . However, the mechanisms of NO-mediated vascular cell injury, particularly in H 2 O 2 -stimulated intact vessels remain unknown. Accumulating evidence suggest that the cytotoxic effects of NO are most likely mediated by its oxidation product, particularly peroxynitrite (ONOO À ), rather than NO itself (Xia et al., 1996; Riobo et al., 2001; Pacher et al., 2007) . NO reacts rapidly with superoxide (O 2 À ) at a diffusion-controlled rate (~1 9 10 10 M À1 s À1 ) to form ONOO À , a strong oxidant capable of oxidizing and nitrating lipid, protein, and DNA, resulting in cell death and tissue injury (Radi et al., 1991; Pacher et al., 2007; Szabo et al., 2007) . Recently, H 2 O 2 has been shown to induce further production of O 2 À and H 2 O 2 mainly through activation of NAD (P)H oxidase (Li et al., 2001; Cai, 2005) , which is considered as an important mechanism for ROS-mediated pathogenesis of cardiovascular diseases. However, whether the interplay between reactive oxygen species, nitric oxide, and peroxynitrite is accountable for H 2 O 2 -induced microvessel barrier dysfunction remains unknown. Currently, the role of ONOO À in the regulation of eNOS activity and NO production, particularly under in vivo conditions, has not been well defined. While some early studies reported that ONOO À induced vasodilation through increased NO production (Liu et al., 1994; Villa et al., 1994) , others on cultured bovine endothelial cells suggested that, although ONOO À increased eNOS activity through enhanced phosphorylation at Ser 1179 , it increased O 2 ÁÀ production, instead of NO 
Materials and Methods

Animal preparation
All animal experiments were conducted on female Sprague-Dawley rats (2-3 months old, 220-250 g; Hilltop Laboratory Animal, Scottdale, PA). All procedures and animal use were approved by the Animal Care and Use Committee at West Virginia University. Rats were anesthetized with pentobarbital sodium (65 mg/kg body wt) administered subcutaneously. A midline surgical incision (1.5-2 cm) was made in the abdominal wall and the mesentery was gently taken out from the abdominal cavity and spread over a glass coverslip attached to an animal tray for studies. The upper surface of the mesentery was continuously superfused with mammalian Ringer's solution at 37°C. Each experiment was performed on one microvessel per animal.
Measurement of Lp in individually perfused rat mesenteric microvessels
Microvessel permeability was assessed by measuring hydraulic conductivity, Lp, using modified Landis technique, which measures the volume flux of water across the microvessel wall. Details have been described previously (Curry and Sarelius, 1983; Kendall and Michel, 1995; He et al., 1996) . Briefly, a single venular microvessel with diameters ranging between 35 and 50 lm was cannulated with a micropipette and perfused with albuminRinger solution (control) containing 1% (vol/vol) hamster red blood cells as markers. A known hydrostatic pressure (40-60 cmH 2 O), controlled by a water manometer, is applied through the micropipette to the vessel lumen, which allows the perfusate to continuously flow through the vessel. For each measurement, the perfused vessel was occluded briefly downstream with a glass rod. The initial ] i was measured in individually perfused microvessels using the fluorescent Ca 2+ indicator fura 2-AM. Experiments were performed on a Nikon Diaphod 300 microscope equipped with a Nikon photometry system. In each experiment, a venular microvessel was cannulated and perfused first with albumin-Ringer solution that contained 10 µmol/L of fura 2-AM for 45 min. The vessel was then recannulated and perfused with albuminRinger solution for 10 min to remove fura 2-AM from the vessel lumen. A segment of fura 2-AM-loaded vessel at least 100 µm away from the cannulation site was then positioned within the measuring window which covered~50 ECs forming the vessel wall. The excitation wavelengths for fura 2-AM were selected by two narrowband interference filters (340 AE 5 and 380 AE 5 nm; Oriel), and the emission was separated with a dichroic mirror (DM400) and a wide-band interference filter (500 AE 35 nm; Oriel). The corresponding FI values (FI 340 and FI 380 , respectively) were collected with a 0.25-sec exposure at each wavelength. Baseline EC [Ca 2+ ] i was measured after fura 2-AM was removed from the vessel lumen with albumin-Ringer perfusion for 10 min. Then the same vessel was recannulated with pipette containing test reagents (e.g., H 2 O 2, ONOO À , L-NMMA, uric acid, LaCl 3, etc.) and the changes in EC [Ca 2+ ] i were measured immediately after the recannulation. At the end of the experiment, the microvessel was superfused with a modified Ringer solution (5 mmol/L of Mn 2+ without Ca 2+ ) and perfused with the same solution that contained ionomycin (10 µmol/L) to bleach the Ca 2+ -sensitive form of fura 2. The background FI due to unconverted fura 2-AM and other Ca 2+ -insensitive forms of fura 2 were subtracted from FI 340 and FI 380 values. The ratios of the two FI values were converted to Ca 2+ concentrations using an in vitro calibration curve (He et al., 1996) .
Measurement of endothelial NO production
Levels of endothelial NO were quantified at cellular level in individually perfused microvessels using a fluorescence imaging system and 4,5-diaminofluorescein diacetate (DAF-2 DA). The experimental rigs were the same as that used for Ca 2+ measurements, except that a 12-bit digital, cooled, charge-coupled device camera (ORCA; Hamamatsu) was used for image acquisition. The excitation wavelength for DAF-2 DA was selected by an interference filter (480/40 nm), and emission was separated by a dichroic mirror (505 nm) and a band-pass barrier (535/50 nm). To minimize photo bleaching, a neutral density filter (0.5 N) was positioned in front of the interference filter and the exposure time was minimized to 0.12 sec at 1-min intervals. All the images were acquired and analyzed using Metafluor software (Universal Imaging). During the experiment, each vessel was continuously perfused with albumin-Ringer solution containing DAF-2 DA (5 µmol/L). NO production was measured after the DAF-2 loading reached the steady state . Basal NO was measured for 10 min before perfusion with test reagents. All images were collected from a group of ECs located at the same focal plane of the vessel wall. At the end of the experiment, the NO donor, sodium nitroprusside (SNP, 50 mmol/L) was applied to the superfusate to ensure sufficient intracellular DAF-2 to react with NO. Quantitative analysis was conducted at the individual EC level using manually selected regions of interest (ROIs) along the vessel wall. Each ROI covers the area of one individual EC as indicated by the fluorescence outline. The tissue autofluorescence was subtracted from all the measured FIs. The changes in FI DAF upon addition of test reagents were expressed as the percentage of FI DAF over the baseline FI 0 (FI/FI 0 *100) . The rate of FI DAF change was derived by the first differential conversion of cumulative FI DAF over time. DAF-2 specificity for NO detection was examined by mixing DAF-2 (10 µmol/L) with albumin-Ringer solution, H 2 O 2 (5, 50 and 500 µmol/L), SNP (20 and 200 µmol/L), hypoxanthine/ xanthine oxidase (0.05 mmol/L /1 mU, 0.5 mmol/L / 10 mU, and 5 mmol/L /100 mU), or peroxynitrite (5, 50, and 500 µmol/L) using the same experimental settings as those used for NO measurement on intact vessels. No significant increase in FI DAF-2 was observed for all the test agents except SNP at 200 µmol/L that caused an accumulative increase in FI DAF-2 , indicating the specificity of DAF-2 as a NO fluorescent indicator. Peroxynitrite at 500 µmol/L caused a small increase in FI DAF , but that concentration is beyond the range we used in the experiments. The representative measurements with each agent are shown in Fig 1. ª 
Solutions and reagents
Mammalian Ringer solution (He et al., 1996) was used for dissecting mesenteries, superfusing tissues, and preparing perfusion solutions. The composition of the mammalian Ringer solution was (in mmol/L) 132 NaCl, 4.6 KCl, 2 CaCl 2 , 1.2 MgSO 4 , 5.5 glucose, 5.0 NaHCO 3 , 20 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), and Na-HEPES. All perfusates used for control and test perfusion contained BSA (10 mg/ml). Fura-2 AM was purchased from Invitrogen. H 2 O 2 (30%), DAF-2, DAF-2 DA, LaCl 3 , L-NMMA, DPI, and DHE were purchased from Sigma. All the fluorescent dyes except for Alexa488-conjugated secondary antibody (in BSA-Ringer solution) were prepared in DMSO for stock solution, and at least 1:1000 dilution was made for the final working solutions. ONOO À and degraded ONOO À were purchased from EMD Millipore and were diluted in the BSA-Ringer solution into final concentrations of 10 or 50 µmol/L. All perfusates containing the test reagents were freshly prepared before each cannulation.
Data analysis and statistics
All values are presented as means AE SD. Each "n" represents the number of vessels (one vessel per rat). Paired We previously demonstrated that H 2 O 2 at pathologically relevant concentrations induced delayed and progressive increases in microvessel Lp, which was initiated by the activation of eNOS and excessive NO production (Zhou et al., 2009; Zhou et al., 2013) . Fig 2A shows Fig. 4A , a marked increase in the DHE FI was observed in both endothelium and pericytes after 30-min perfusion of H 2 O 2 (10 µmol/L), which was abolished by pretreatment of the vessels with an inhibitor of NADPH oxidase, diphenylene iodonium (DPI, 20 µmol/L,). The mean FIs of DHE were 48 AE 2.5, 141 AE 15.6, and 59 AE 0.5 AU in BSA-Ringer (control, n = 6), H 2 O 2 (n = 5), and H 2 O 2 plus DPI-perfused vessels (n = 6), respectively ( Fig. 4B. P One-way ANOVA with Tukey post hoc test were used for comparison between groups and paired t-test was used for paired measurements conducted in the same vessel (A and D). Two-way ANOVA with Tukey post hoc test were used for comparison of data between groups at the same time points (B and C), ****P < 0.0001. ***P < 0.001, **P < 0.005, *P < 0.05, ns P ≥ 0. ] i from a mean peak value of 403 AE 43.0 (n = 5) to 139 AE 30.6 nmol/L (n = 4, P = 0.002), and completely prevented the H 2 O 2 -induced increase in Lp (Lp test / Lp control ) from 9.3 AE 1.34 (n = 5) to 1.0 AE 0.08 times the control level (n = 4, P = 0.003). All values are compared after 2-h perfusion of H 2 O 2 (10 µmol/L). Fig. 5A ,B show the representative experiments and Fig. 5C shows the results summary. Fig. 6A,D) . However, extending the perfusion duration to 1 and 2 h resulted in time-and dose-dependent Lp increases similar to that observed in H 2 O 2 -perfused vessels (Fig 2A) . Lp increased significantly to 2.8 AE 0.45 (P = 0.03) and 5.9 AE 0.44 (P = 0.003) times the control at 10 µmol/L, and to 6.0 AE 0.57 and 12.0 AE 0.96 times the control at 50 µmol/L (P < 0.001) after 1 and 2 h of ONOO À perfusion, respectively (Fig. 6B,D , n = 4-6 per group). We also examined the effect of degraded peroxynitrite on microvessel Lp in two vessels. No changes in Lp were observed after 1-h perfusion of degraded peroxynitrite (50 µmol/L). Fig 6C represents perfused vessels (n = 4). Perfusion of vessels with ONOO À induced an immediate increase in NO production with an initial peak rate at 31.9 AE 6.43% min -1 for 2 min followed by a rate of 6.5 AE 2.30% min -1 till 10 AE 1.4 min (Fig. 8C ). This initial increase in FI DAF (DFI%) was 332 AE 25% of baseline control. With continuous ONOO À perfusion, a second peak of NO production occurred at~18 min with a rate of 16.6 AE 4.50% min -1 and fell to 1.9 AE 0.10% min À1 at~62 min (Fig. 8C ). This second phase of FI increase (DFI%) was 222.0 AE 18.50% of the control (Fig. 8A,B) . Control experiments in vessels perfused with albumin-Ringer solution (n = 3) only showed basal NO production at a rate of 0.1%/min (Fig. 8A,B) . By comparing ONOO À -induced NO production with the time course of the increases in EC [Ca 2+ ] i , we found that the initial increase in NO production occurred in the absence of increased EC [Ca 2+ ] i , whereas the second phase of NO production occurred concomitantly with increases in EC [Ca 2+ ] i (Fig. 8C) . To examine the role of Ca 2+ influx in ONOO À -induced NO production, NO was measured on four vessels pretreated with LaCl 3 (50 µmol/L). As described above (Fig. 7A) were measured, NO measurements showed that inhibition of Ca 2+ influx by 3 had no effect on the ONOO-induced initial NO production, but attenuated the second phase of NO production (DFI% reduced from 222.0 AE 18.50% to 15.0 AE 3.25% of control, Fig. 7B,C) . These data suggest that ONOO À -induced initial NO does not require increased Ca 2+ influx, but the second phase of NO production was initiated by the increased EC [Ca 2+ ] i . We also examined whether ONOO À -induced NO production was a result of NOS activation. Treatment of vessels with NOS inhibitor, L-NMMA (2 mmol/L), 20 min before and during ONOO À perfusion significantly decreased ONOO À -induced NO production. FI DAF reduced from 570 AE 141.0% to 154 AE 50.0 % of control, (n = 4, Fig. 8B ).
Discussion
Our study, using quantitative measurement of microvessel permeability in combination with fluorescence and confocal microscopy, identified a novel mechanism by which H 2 O 2 , a commonly known reactive oxygen species essential for the pathogeneses of cardiovascular diseases, interplays with superoxide, eNOS-derived NO, and ONOO À , leading to EC Ca 2+ overload, vascular cell damage, and barrier dysfunction in intact vessels. H 2 O 2 at a pathophysiological relevant concentration (10 µmol/L) (Lacy et al., 2000; Banerjee et al., 2003) induced eNOS activation with a large amount of NO production. Instead of causing an immediate increase in microvessel permeability that occurred in PAF or other inflammatory mediator-stimulated microvessels (He et al., 1996; Zhu and He, 2005; Zhou and He, 2010) , this large amount of NO (~10 times the amount of NO detected in PAF-perfused microvessels) was shown to be responsible for intracellular Ca 2+ accumulation, subsequent cell apoptosis, and the delayed and progressive increases in microvessel permeability ( Zhou et al., 2013 Fig. 9 .
Role of eNOS-derived NO production in the regulation of H 2 O 2 -induced microvessel barrier dysfunction
Previous studies from our laboratory and others have demonstrated that eNOS-derived excessive NO plays an essential role in inflammatory mediators-induced vascular leakage (Mayhan, 1992; Yuan et al., 1993; He et al., 1997; Hatakeyama et al., 2006; Zhou and He, 2010; He, 2011). A typical inflammatory mediator-induced increase in microvessel permeability usually is immediate and transient, which is associated with the transient formation of endothelial gaps between adjacent ECs (Majno and Palade, 1961; Wu and Baldwin, 1992; Baluk et al., 1997; Jiang et al., 2008; . In contrast to the inflammatory mediator-induced immediate and transient increase in microvessel permeability, H 2 O 2 caused a delayed and progressive increase in microvessel Lp in a dose-and time-dependent manner (Zhou et al., 2009; Zhou et al., 2013) , indicating the involvement of different mechanisms. Our study demonstrated that H 2 O 2 at pathophysiologically relevant concentrations (10 µmol/ L) induce both Ca
2+
-independent and -dependent eNOS activation and the excessively produced NO triggers caspase activation and the impairment of intracellular Ca 2+ homeostasis, leading to vascular cell apoptosis and consequently delayed and progressive increases in microvessel permeability ( Zhou et al., 2013) . In this case, the H 2 O 2 -induced initial NO production in the absence of increased ]i, although being five times more than that observed in PAF-perfused vessels, did not cause immediate increase in microvessel permeability (Zhu and He, 2005; Zhou and He, 2010) . These findings suggest that the excessive NO-mediated vascular barrier dysfunction may depend on the activation of other concurrent signaling pathways, such as increased EC [Ca 2+ ] i , or the location of NO production (Sanchez et al., 2006) , thus the pattern of NO-mediated increase in microvessel permeability is stimulus specific.
Our previous study illustrated that the H 2 O 2 -induced initial phase of eNOS activation is predominantly through increased phosphorylation at Ser 1177 independent of elevated EC [Ca 2+ ] i , whereas the second phase of eNOS activation is mainly triggered by increased EC [Ca 2+ ] i and Ca 2+ /CaM binding (inhibited by caveolin-1, CAV-1), coordinated with decreased phosphorylation at Thr 495 (Zhou et al., 2013 (Fig. 2C) . The sustained increase in EC [Ca 2+ ] i , an indication of impaired Ca 2+ homeostasis, appears to be essential for vascular cell apoptosis and subsequently increased microvessel permeability.
induced increases in microvessel Lp
Although NO has been reported to have potential cytotoxic effects, many of them are attributed to its oxidation product, particularly ONOO À rather than NO itself (Xia et al., 1996; Riobo et al., 2001; Pacher et al., 2007) . NO reacts rapidly with superoxide to form ONOO À , a strong oxidant, capable of oxidizing and nitrating lipid, protein, and DNA, resulting in cell death and tissue injury (Radi et al., 1991; Pacher et al., 2007; Szabo et al., 2007) . Consistent with this concept, our results support that H 2 O 2 -induced excessive NO-derived ONOO À is the key contributing to increased microvesel permeability in intact rat venules. This conclusion is supported by the following evidence: (1) H 2 O 2 induced concomitant NO and superoxide production, the two elements required to form ONOO À , (2) H 2 O 2 induced NO-dependent extensive protein tyrosine nitration (a commonly recognized biomarker for ONOO À ) in the vascular wall, (3) uric acid, an endogenous ONOO À scavenger (Ames et al., 1981; Hooper et al., 1998; Tsukada et al., 2000; Walford et al., 2004; Kuzkaya et al., 2005) , prevented H 2 O 2 -induced impairment of Ca 2+ homeostasis and increases in microvessel permeability; and (4) exogenously applied ONOO À induced a delayed and progressive increases in EC [Ca 2+ ] and microvessel Lp in a dose-and time-dependent manner, a pattern similar to that observed in H 2 O 2 -perfused vessels.
The H 2 O 2 -induced superoxide production has been considered as an important feed-forward mechanism for ROS-mediated pathogenesis of cardiovascular diseases (Cai, 2005) . In vitro studies showed that inhibition of p22 phox by siRNA and knockout of gp91 phox (the two transmembrane subunits of NAD(P)H oxidase) prevented the H 2 O 2 -induced increases in superoxide production in vascular endothelial cells (Li et al., 2001; Djordjevic et al., 2005) . Using confocal microscopy, we detected a~three-fold increase in DHE FI in the nuclei of both ECs and pericytes as early as 30 min of H 2 O 2 perfusion, indicating a large amount of superoxide production (Fig. 4) . Within the same period, NO production increased~eightfold (indicated by the increased FI DAF-2 , Fig. 2B ). When both NO and superoxide are produced in close proximity, a spontaneous ONOO À formation is expected in the H 2 O 2 -perfused vessels. Our results that DPI, a commonly used NAD(P)H oxidase inhibitor, prevented the increases in superoxide production in both endothelium and pericytes in H 2 O 2 -perfused intact vessels (Fig. 4) (Fig. 3) . Nitrotyrosine has been recognized as an important biomarker for ONOO À and an indication of systemic nitroxidative stress (Prutz et al., 1985; Reiter et al., 2000; Radi, 2004; Radi, 2013) . The application of uric acid, an endogenous ONOO À scavenger (Hooper et al., 1998; Tsukada et al., 2000; Walford et al., 2004; Kuzkaya et al., 2005) ] i and microvessel Lp in a dose-and time-dependent manner (Fig. 6) , a similar pattern to that observed in H 2 O 2 -perfused vessels (Zhou et al., 2009; Zhou et al., 2013) , and inhibition of Ca 2+ influx with LaCl 3 prevented Ca 2+ accumulation in ECs and the increased Lp in peroxynitrite-perfused vessels (Fig. 7) . These results demonstrate a direct role of ONOO À in the impairment of Ca 2+ homeostasis and vascular barrier dysfunction.
Interaction between ONOO À and eNOSderived NO production: a self-promoted amplification, contributing to ONOO À -mediated vascular damage and barrier dysfunction Currently, the role of ONOO À in eNOS activity, particularly under in vivo conditions, remains unknown. While some early studies reported that ONOO À induced coronary vasodilation in isolated rat hearts and coronary arterial rings of dogs through increased NO production (Liu et al., 1994; Villa et al., 1994) production, rather than that of NO . Using quantitative fluorescent imaging in intact venules, our study demonstrated that ONOO À induced a large amount of NO that was abolished by L-NMMA, indicating eNOSderived NO production (Fig. 7) . Similar to what have been observed in H 2 O 2 -perfused vessels (Shen et al., 1998) , ONOO À induced two phases of eNOS-derived NO production. As shown in Fig. 8C , the initial NO production with a higher peak rate occurred in the absence of increases in EC [Ca 2+ ] i , whereas the second phase NO production is slow and concomitant with progressively increased EC [Ca 2+ ] i . Blockade of Ca 2+ influx by LaCl 3 did not affect the initial NO production, but abolished the NO production in the second phase (Fig8B,C) , suggesting that peroxynitrite-induced initial eNOS activation is independent on Ca 2+ increase, whereas the second phase of eNOS activation is Ca 2+ dependent. This interesting finding suggests that ONOO À , a downstream product formed by NO and superoxide, further amplified NO production, resulting in an amplification of NO-dependent signaling and augmented ONOO À -mediated vascular cell damage and barrier dysfunction.
Methodology assessment
Vascular barrier function is usually referred to vascular permeability to both fluid and solutes. In this study, microvascular permeability is determined by measuring hydraulic conductivity, Lp, one of the three permeability coefficients that assesses the transport of fluid. Although microvessel permeability to different sizes of solute was not measured, experimental evidence showed that Lp well correlates with the transports of small-to intermediate-sized molecules (Michel and Curry, 1999) . Importantly, most of the increases in solute flux (including large molecules) are coupled to water flows. When permeability increases, the magnitude changes in fluid or small molecules could be different from macromolecules, depending on transport pathways involved, they usually followed the same time course as the changes in Lp (Rutledge et al., 1990; Rutledge et al., 1995; Michel and Curry, 1999) . The permeability coefficients are more quantitative and accurate measures of vascular wall properties than the commonly used flux or leaky sites, since they are not affected by unknown variations of hemodynamic factors and surface area for transport (Michel and Curry, 1999 This constantly refreshed perfusate makes a fundamental difference from the one time addition of reactive reagents to the tissue or cell culture medium that results in an immediate reaction of the reactive agents with the cells and other components in the medium and lost it activity quickly. In those studies, usually hundreds of µmol/L or mmol/L concentrations of peroxide (far more than the pathological concentrations detected in the plasma) were used in order to show some of the responses Kevil et al., 2000; Lee et al., 2006; Jin et al., 2012; Suresh et al., 2015 (He et al., 1996; Zhou et al., 2013) , the cell marker-free perfusate in the presence of 1% BSA is able to well maintain the baseline Lp, EC [Ca 2+ ] i and basal NO up to 2-h perfusion period which we have tested.
Compared to normal blood, our perfused vessels lack blood cells, plasma SOD, catalase, and substances released from blood cells, which could affect the production of ROS, reactive nitrogen species (RNS), and NO. Under diseased conditions, measured plasma peroxide levels are close to 10 µmol/L (Lacy et al., 2000) . We consider that the detected plasma H 2 O 2 level is the effective level of peroxide that affects endothelial cells lining the vascular walls and is the net balance of the constant production of ROS and its reaction with plasma enzymes such as SOD and catalase in the vasculature. Our experimental conditions bypassed the constant ROS production and catalytic processes when blood is circulating in the vasculature, and applied this pathologically relevant net plasma H 2 O 2 concentration to the vessel lumen, which allows us to investigate its direct effect on vascular walls and avoid other confounding factors.
The use of DHE to detect intracellular formation of superoxide has been assessed and characterized by many studies. The formation of 2-hydroxyethidium is considered as the specific reaction of DHE with superoxide and not with other biologically relevant oxidants, which can be separated from its parent DHE and ethidium (Zielonka et al., 2008) , including vessel segment studies and confirmed with high performance liquid chromatography (HPLC, Dikalov et al. (2007) ). The advantage of using the DHE fluorescence imaging in our perfused intact vessels is its ability to provide spatial detection of superoxide production at vascular walls using the same experimental approach where other signaling changes and microvessel permeability are measured, which could not be achieved with other methods. The pharmacological inhibitors used in this study such as DPI and uric acid showed consistent results as NADPH oxidase inhibitor and ONOO À scavenger (Hooper et al., 1998; Kean et al., 2000; Kim et al., 2018; Pietruczuk et al., 2019) , respectively, even though they may have nonspecific effects. These additional supporting evidence, together with the results of DHE staining and the nitrotyrosine immunostaining provided multiple lines of evidence to support the H 2 O 2 -induced superoxide production and subsequent ONOO À formation. One potential concern is the specificity of using DAF-2 to measure NO in the presence of the reactive oxidants (Jourd'heuil, 2002) . DAF-2 DA has been used to measure intracellular NO in a wide range of biological systems. However, since the interaction of DAF-2 with NO to form DAF-2 triazole form (DAF-2T, high fluorescence product) requires the presence of O 2 , it raises concerns about the potential effects of oxidants on DAF-2T conversion (Jourd'heuil, 2002; Wardman, 2007; Hall and Garthwaite, 2009 ). To address this issue, we have carefully characterized this NO probe in individually perfused vessels and demonstrated the cautious procedures to avoid non-NO-related DAF-2 FI . We also assess the specificity of DAF-2 by measuring its direct reaction with H 2 O 2 , superoxide (generated by HX/XO), and ONOO À in solution using the same imaging system when NO was measured in intact microvessels. The results shown in Fig 1 demonstrated that DAF-2 (10 µmol/L, closer to intracellular DAF-2 concentration when 5 µmol/L DAF-2 DA was used to load vessels) does not directly interact with ROS and ONOO À in the absence of NO within the reagents' concentrations we used in the experiments, although at this point we may not exclude the possibility that the presence of oxidants may facilitate the DAF-2T formation with increased flux of NO and enhance DAF-2 FI. Our results show that the use of NOS inhibitor completely blocked the H 2 O 2 -or ONOO À -induced increases in DAF-2 FI indicating a strong association between DAF-2T and increased NO production. We consider that DAF-2 is the most reliable specific NO indicator comparing with other up to date methods. Since the H 2 O 2 -and ONOO À -induced DAF-2 FI changes are in large magnitude, some contributions from oxidant effect will not change the nature of our findings. Especially, our previous studies have provided the validation of the NO measurements with DAF-2 by conducting parallel studies with immunostaining of eNOS activation (Zhou et al., 2013) .
In conclusion, our study uncovered a novel mechanism of elevated H 2 O 2 -mediated microvascular dysfunction further activate eNOS and augment NO production, resulting in a self-promoted augmentation of nitroxidative stress and subsequent vascular cell damage and vascular barrier dysfunction. The signaling cascades and sequential functional changes illustrated in Fig. 9 offer novel insight into ROS and/or RNS-mediated pathogenesis of cardiovascular diseases.
